| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5104892 | Value in Health | 2016 | 9 Pages |
Abstract
There is value in investigating cost-effectiveness by different subtypes within a disease. In this example of breast cancer, the poorer the prognosis, the greater the health gains from a CCC and the better the cost-effectiveness. Incorporating heterogeneity in a cost-utility analysis is important and can inform resource allocation decisions. It is also feasible to undertake in practice.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Nisha MPH, Giorgi PhD, Tony PhD,